Evaluation of placental syndecan-1 expression in early pregnancy as a predictive fetal factor for pregnancy outcome

Prenatal Diagnosis

Volumn 32, Issue 2, 2012, Pages 131-137

  Schmedt, Anna ^a   Götte, Martin ^a   Heinig, Jörg ^a   Kiesel, Ludwig ^a   Klockenbusch, Walter ^a   Steinhard, Johannes ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SYNDECAN 1;

ADULT; ARTICLE; BIOMETRY; CHORION VILLUS; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL SMOKING; PLACENTA; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION;

ADULT; BIOLOGICAL MARKERS; CHORIONIC VILLI SAMPLING; FEMALE; FETAL DEVELOPMENT; FETAL WEIGHT; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; PLACENTA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; PROSPECTIVE STUDIES; SYNDECAN-1; ULTRASONOGRAPHY, PRENATAL; YOUNG ADULT;

ANIMALIA; NICOTIANA TABACUM;

EID: 84858317967     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2908     Document Type: Article

References (23)

1. Crescimanno C, Marzioni D, Paradinas FJ, et al. Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast. J Pathol 1999;189:600-8.
2. Jokimaa V, Inki P, Kujari H, et al. Expression of syndecan-1 in human placenta and decidua. Placenta 1998;19:157-63.
3. Götte M, Joussen AM, Klein C, et al. Role of Syndecan-1 in Leukocyte -Endothelial interactions in the ocular vasculature. Invest Ophthalmol Vis Sci 2002;43:1135-41.
4. Elenius V, Götte M, Reizes O, et al. Inhibition by the soluble syndecan-1 ectodomain delays wound healing in syndecan-1 overexpressing mice. J Biol Chem 2004;279:41928-35.
5. Elenius K, Vainio S, Laato M, et al. Induced expression of syndecan in healing wounds. J Cell Biol 1991;114:585-95.
6. Yip GW, Smollich M, Götte M. Therapeutic value of glycosaminoglycans in cancer. Mol Cancer Ther 2006;5:2139-48.
7. Kharabi Masouleh B, Ten Dam GB, Wild MK, et al. Role of the heparan sulfate proteoglycan syndecan-1 (CD138) in delayed-type hypersensitivity. J Immunol 2009;182:4985-93.
8. Nikolova V, Koo C-Y, Ibrahim SA, et al. Differential role of membrane-bound and soluble forms of syndecan-1 ectodomains in breast cancer progression. Carcinogenesis 2009;30:397-407.
9. Baston-Büst DM, Götte M, Janni W, et al. Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns. Reprod Biol Endocrinol 2010;8:133.
10. Huppertz B, Peeters LL. Vascular biology in implantation and placentation. Angiogenesis 2005;8:157-67.
11. Jokimaa VI, Kujari HP, Ekholm EM, et al. Placental expression of syndecan 1 is diminished in preeclampsia. Am J Obstet Gynecol 2000;183:1495-8.
12. Sanderson RD, Bernfield M. Molecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epithelia. Proc Natl Acad Sci USA 1988;85:9562-6.
13. Ferrazzi E, Bulfamante G, Mezzopane R, et al. Uterine Doppler velocimetry and placental hypoxic-ischemic lesion in pregnancies with fetal intrauterine growth restriction. Placenta 1999;20:389-94.
14. Salihu HM, Aliyu MH, Kirby RS. In utero nicotine exposure and fetal growth inhibition among twins. Am J Perinatol 2005;22:421-7.
15. Steyn K, de Wet T, Saloojee Y, et al. The influence of maternal cigarette smoking, snuff use and passive smoking on pregnancy outcomes: the Birth To Ten Study. Paediatr Perinat Epidemiol 2006;20:90-9.
16. Baroni T, Bellucci C, Lilli C, et al. Human cleft lip and palate fibroblasts and normal nicotine-treated fibroblasts show altered in vitro expressions of genes related to molecular signaling pathways and extracellular matrix metabolism. J Cell Physiol 2010;222:748-56.
17. Bernfield M, Götte M, Park PW, et al. Functions of Cell Surface Heparan Sulfate Proteoglycans. Ann Rev Biochem 1999;68:729-77.
18. Wang Z, Götte M, Bernfield M, et al. Constitutive and accelerated shedding of murine syndecan-1 is mediated by cleavage of its core protein at a specific juxtamembrane site. Biochemistry 2005;44:12355-61.
19. Götte M. Syndecans in inflammation. FASEB J 2003;17:575-91.
20. Zhao Z, Reece EA. Nicotine-induced embryonic malformations mediated by apoptosis from increasing intracellular calcium and oxidative stress. Birth Defects Res B Dev Reprod Toxicol 2005;74:383-91.
21. McDermott SP, Ranheim EA, Leatherberry VS, et al. Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development. Oncogene 2007;26:1407-16.
22. Svennevig K, Kolset SO, Bangstad HJ. Increased syndecan-1 in serum is related to early nephropathy in type 1 diabetes mellitus patients. Diabetologia 2006;49:2214-16.
23. Sun J, Jin Q, Zhang C, et al. Polymorphisms in the bovine ghrelin precursor (GHRL) and Syndecan-1 (SDC1) genes that are associated with growth traits in cattle. Mol Biol Rep 2011;38:3153-60.